AMI Pharma – Amsterdam Academic Ventures

Our portfolio

AMI Pharma

AMI Pharma develops therapeutics compounds for Type 1 Diabetes and autoimmune diseases. Their research, based on IP from Amsterdam UMC and Wageningen University & Research, aims to bring new treatments to the clinical trials. AMI Pharma leverages extensive pre-clinical and clinical data to advance their therapeutic pipeline.

Industry: Diabetes, Metabolic Disorders, Therapeutics

Want to get in contact about AMI Pharma?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Developing gene therapy solutions for heart rhythm disorders.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing novel treatments for Parkinson’s disease and dopamine disorders.

Personalized e-health recovery plans for post-surgery rehabilitation.

Developing gene therapy solutions for heart rhythm disorders.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing novel treatments for Parkinson’s disease and dopamine disorders.

Personalized e-health recovery plans for post-surgery rehabilitation.